Natural Peptides Inducing Cancer Cell Death: Mechanisms and Properties of Specific Candidates for Cancer Therapeutics

Plinio A Trinidad-Calderón1, Carlos Daniel Varela-Chinchilla1, Silverio García-Lara1

  • 1Tecnológico de Monterrey, School of Engineering, and Sciences, Avenida Eugenio Garza Sada 2501, Monterrey 64849, Nuevo León, Mexico.

Insights

Bioactive peptides derived from proteins show promise as novel anticancer drugs. This review highlights specific peptide candidates and their tumor-killing mechanisms, crucial for developing effective cancer therapies.

Area of Science:

  • Biochemistry and Molecular Biology
  • Pharmacology
  • Oncology

Background:

  • Cancer is a leading cause of death, with growing incidence and complex mechanisms necessitating novel therapeutic strategies.
  • Proteins contain encrypted bioactive peptides with demonstrated anticancer effects, offering a promising avenue for drug development.
  • Existing research on peptide therapeutics lacks detailed molecular mechanism insights and interaction network analyses.

Purpose of the Study:

  • To review specific bioactive peptides with confirmed anticancer effects and known molecular mechanisms.
  • To identify key features that qualify peptides as therapeutic candidates for cancer treatment.
  • To elucidate the mechanisms by which these peptides induce tumor cell death.

Main Methods:

  • Literature review of scientific databases and research articles.
  • Analysis of peptide sequences and their reported anticancer activities.
  • Investigation of documented molecular mechanisms underlying peptide-mediated cancer cell death.

Main Results:

  • Several specific bioactive peptides with confirmed anticancer properties were identified.
  • Key features contributing to peptide efficacy, including sequence and structure, were highlighted.
  • Mechanisms of tumor cell death induced by these peptides, such as apoptosis and cell cycle arrest, were detailed.

Conclusions:

  • Bioactive peptides represent a significant source for developing novel, targeted cancer therapeutics.
  • Understanding peptide mechanisms is vital for optimizing efficacy and minimizing toxicity to healthy cells.
  • Further research into peptide interaction networks can enhance their therapeutic potential and overcome drug resistance.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.0K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
3.9K